Purple Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	0	0	0	0	0	1	0.1	0	0	0	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	900.00%	-	-	-	-	Upgrade
Gross Profit	0	0	0	0	0	1	0.1	0	0	0	Upgrade
Selling, General & Admin	5.24	6.28	6.11	6	4.39	5.2	6.4	3	1.51	1.27	Upgrade
Research & Development	17.03	16.32	11.83	7.24	2.28	5.27	4.64	4.18	2.56	3.19	Upgrade
Other Operating Expenses	0	0	0	0	0	-0.74	1.03	0	0	0.72	Upgrade
Operating Expenses	22.27	22.6	17.93	13.24	6.67	9.72	12.07	7.18	4.07	5.18	Upgrade
Operating Income	-22.27	-22.6	-17.93	-13.24	-6.67	-8.72	-11.97	-7.18	-4.07	-5.18	Upgrade
Interest Expense / Income	2.2	0.07	0.21	0.06	0.18	0.58	0.03	0.06	0.23	0.35	Upgrade
Other Expense / Income	-44.35	-44.34	-36.53	-41.3	-12.92	-14.5	-24.17	-19.37	-8.5	-0.27	Upgrade
Pretax Income	19.88	21.67	18.38	28	6.07	5.2	12.18	12.13	4.2	-5.25	Upgrade
Income Tax	0	0	0	0	0.22	0	0	0	0	0	Upgrade
Net Income	19.88	21.67	18.38	28	5.85	5.2	12.18	12.13	4.2	-5.25	Upgrade
Net Income Growth	-8.25%	17.86%	-34.34%	378.62%	12.50%	-57.30%	0.43%	188.55%	-	-	Upgrade
Shares Outstanding (Basic)	198	178	18	12	2	1	9	6	1	0	Upgrade
Shares Outstanding (Diluted)	-	-	18	12	2	1	9	6	1	0	Upgrade
Shares Change	11.37%	913.93%	52.76%	493.78%	36.34%	-84.98%	64.30%	497.99%	329.53%	173.08%	Upgrade
EPS (Basic)	-	-12.00	-10.10	-25.00	-27.50	-3.90	-13.70	-21.10	-44.00	-234.00	Upgrade
EPS (Diluted)	-	-12.00	-10.10	-25.00	-27.50	-3.90	-13.70	-21.10	-44.00	-234.00	Upgrade
Free Cash Flow	-19.93	-16.96	-15.37	-12.25	-5.59	-8.5	-8.64	-6.27	-3.32	-4.53	Upgrade
Free Cash Flow Per Share	-1.00	-0.95	-8.75	-10.65	-28.87	-59.81	-9.14	-10.90	-34.46	-201.98	Upgrade
Gross Margin	-	-	-	-	-	100.00%	100.00%	-	-	-	Upgrade
Operating Margin	-	-	-	-	-	-872.00%	-11966.00%	-	-	-	Upgrade
Profit Margin	-	-	-	-	-	520.00%	12177.00%	-	-	-	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-849.60%	-8640.00%	-	-	-	Upgrade
Effective Tax Rate	-	-	-	-	3.56%	-	-	-	-	-	Upgrade
EBITDA	22.27	21.94	18.83	28.3	6.43	5.78	12.21	12.19	4.43	-4.91	Upgrade
EBITDA Margin	-	-	-	-	-	578.30%	12207.00%	-	-	-	Upgrade
Depreciation & Amortization	0.2	0.2	0.23	0.24	0.18	0.01	0	0	0	0	Upgrade
EBIT	22.08	21.74	18.6	28.06	6.25	5.78	12.2	12.19	4.43	-4.91	Upgrade
EBIT Margin	-	-	-	-	-	577.60%	12203.00%	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).